Non-regulatory Press releases

Malmö, Sweden, 7th November 2018 You can also download the press release as PDF here PILA PHARMA announces good safety of XEN-D0501 following single doses in patients with type 2 diabetes PILA PHARMA AB, a pharmaceutical company based in Malmö, Sweden, is pleased to announce that on November 1st, 2018, the dosing of patients in its first trial PP-CT01, studying…

Malmö, Sweden, 6th December 2017 You can also download the press release as PDF here PILA PHARMA passes the start-up phase, prepares for efficacy trials and increases focus on 'Effective and Affordable Medicine' by electing the health economist Ulrikka Klarskov Kjær to the Board of Directors PILA PHARMA, founded in 2014, now counts +10 core members and has thus passed…

Malmö, Sweden, 9th  May 2017 You can also download the press release as PDF here PILA PHARMA has carried out a fully subscribed new issue of shares PILA PHARMA AB, a Swedish pharmaceutical company based in Malmö, is pleased to announce that the company has raised SEK 10 million through a fully subscribed new issue shares. Both existing shareholders and new investors…

Malmö, Sweden, 6th  March 2017 You can also download the press release as PDF here PILA PHARMA receives regulatory approval of its first clinical trial application and appoints new Chairman of the Board PILA PHARMA AB, a Swedish pharmaceutical company based in Malmö, Sweden, is pleased to announce that it has received regulatory approval of its first clinical trial application thus permitting the…